{"id":481343,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-08-28] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T16:26:26.498000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-08-28.html?wbdisable=true","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-08-28] August 28, 2025 Our file number: 25-105622-852 The purpose of this Notice of Amendment is to announce the addition of artesunate, crovalimab, osilodrostat, and quizartinib to the Prescription Drug List…","rawSnapshotUrl":"/api/snapshots/raw/481343","browseUrl":"https://replay.healtharchive.ca/job-6/20260106162626/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-08-28.html?wbdisable=true#ha_snapshot=481343","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}